Common use of Purpose of the Specification Clause in Contracts

Purpose of the Specification. To ensure a consistent and equitable approach across England a common national service specification must be used to govern the provision and monitoring of Down’s, Xxxxxxx’ and Patau’s syndromes Screening (Trisomy 21, 18 &13) as part of the Fetal Anomaly Screening Programme (FASP). The purpose of the service specification is to outline the service and quality indicators expected by NHS England for the population for whom it is responsible and which meets the policies, recommendations and standards of the NHS Screening programmes. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions which may apply, e.g. the Health and Social Care Act 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • current FASP guidance xxxxx://xxx.xxx.xx/topic/population-screening- programmes/fetal-anomaly • FASP Ultrasound Practitioners Handbook xxxxx://xxx.xxx.xx/government/publications/fetal-anomaly- screening-ultrasound-practitioners-handbook • FASP Laboratory Handbook xxxxx://xxx.xxx.xx/government/publications/fetal- anomaly-screening-laboratory-handbook-xxxxx-xxxxxxx-and-pataus- syndromes • any separate service specifications for the screening laboratory used by the Provider for antenatal screening services • UK NSC Guidance, Managing Safety Incidents in the English NHS National Screening Programmes xxxxx://xxx.xxx.xx/government/publications/managing-safety-incidents-in- nhs-screening-programmes • Guidance & updates on Key Performance Indicators xxxxx://xxx.xxx.xx/government/collections/nhs-screening-programmes-national- data-reporting • Clinical Excellence (NICE) Clinical guideline 62 Antenatal care June 2010 xxxx://xxx.xxxx.xxx.xx/guidance/CG62 • National Institute for Health and Clinical Excellence (NICE) Clinical guideline CG 129 Antenatal care September 2011 • Royal College of Radiologists. xxxxx://xxx.xxx.xx.xx/publication/standards- provision-ultrasound-service • Service Specification Number 17 Fetal Anomaly Screening xxxxx://xxx.xxxxxxx.xxx.xx/commissioning/wp-content/uploads/sites/12/2016/02/serv- spec-17.pdf • ‘Maternity Pathway Payments: Who pays for what?-Aspects of the Maternity Pathway Payment for the Screening and Immunisations Programmes June 2015 xxxxx://xxx.xxxxxxx.xxx.xx/expo/wp- content/uploads/sites/18/2015/06/who-pays-mpp-upd-06-2015.pdf

Purpose of the Specification. To ensure a consistent and equitable approach across England England,a common national service specification must be used to govern the provision and monitoring of Down’s, Xxxxxxx’ and Patau’s syndromes Screening the NHS Newborn Blood Spot (Trisomy 21, 18 &13NHS NBS) as part of the Fetal Anomaly Screening Programme (FASP)screening services. The purpose of the service specification for the NBS Screening Programme is to outline the service and quality indicators expected by NHS England and NHS Improvement for the its responsible population for whom it is responsible and which meets the evidence base, policies, recommendations and standards of the NHS UK National Screening programmesCommittee. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions which that may apply, e.g. the Health and Social Care Act 2008 2012 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • current FASP guidance xxxxx://xxx.xxx.xx/topic/population-screening- programmes/fetal-anomaly • FASP Ultrasound Practitioners Handbook xxxxx://xxx.xxx.xx/government/publications/fetal-anomaly- Programme standards xxxxx://xxx.xxx.xx/government/collections/nhs-population- screening-ultrasoundprogramme-practitionersstandards • Programme national annual data reporting xxxxx://xxx.xxx.xx/government/ collections/newborn-handbook • FASP Laboratory Handbook xxxxx://xxx.xxx.xx/government/publications/fetal- anomalyblood-spot-screening-laboratoryprogramme-handbook-xxxxx-xxxxxxxstandards-and-pataus- syndromes data • any separate service specifications for the NHS screening laboratory used by the Provider for antenatal programmes xxxxx://xxx.xxx.xx/government/collections/nhs- screening-programmes-national-data-reporting • NHS population screening services failsafe procedures xxxxx://xxx.xxx.xx/government/ collections/nhs-population-screening-failsafe-procedures • UK NSC GuidanceProgramme supporting publications xxxxx://xxx.xxx.xx/government/collections/ newborn-blood-spot-screening-programme-supporting-publications • Safety concerns, safety incidents and serious incidents. Managing Safety Incidents in the English NHS National Screening Programmes xxxxx://xxx.xxx.xx/government/publications/managing-safety-incidents-in- xxxxx://xxx.xxx.xx/government/ publications/managing-safety-incidents-in-nhs-screening-programmes • Guidance & updates on Key Performance Indicators xxxxx://xxx.xxx.xx/government/collections/nhs-screening-programmes-national- data-reporting • Clinical Excellence (NICE) Clinical guideline 62 Antenatal care June 2010 xxxx://xxx.xxxx.xxx.xx/guidance/CG62 • National Institute for Health and Clinical Excellence (NICE) Clinical guideline CG 129 Antenatal 37 Routine and postnatal care September 2011 of women and their babies 2006 xxxx://xxx.xxxx.xxx.xx/ guidance/cg37 The national screening team in Public Health England (PHE Screening) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • Royal College developing and monitoring standards • producing public information leaflets • quality assurance of Radiologists. xxxxx://xxx.xxx.xx.xx/publication/standards- provision-ultrasound-service local screening services • Service Specification Number 17 Fetal Anomaly enabling accessible training and education Providers should subscribe to the PHE Screening xxxxx://xxx.xxxxxxx.xxx.xx/commissioning/wp-content/uploads/sites/12/2016/02/serv- spec-17.pdf • ‘Maternity Pathway Payments: Who pays for what?-Aspects of the Maternity Pathway Payment blog for the Screening latest national news and Immunisations Programmes June 2015 xxxxx://xxx.xxxxxxx.xxx.xx/expo/wp- content/uploads/sites/18/2015/06/who-pays-mpp-upd-06-2015.pdfupdates. National documentation and guidance is published on XXX.XX.‌‌‌‌

Purpose of the Specification. To ensure a consistent and equitable approach across England a common national service specification must be used to govern the provision and monitoring of Down’s, Xxxxxxx’ the linked antenatal and Patau’s syndromes newborn NHS Sickle Cell and Thalassaemia (SCT) Screening (Trisomy 21, 18 &13) as part of the Fetal Anomaly Screening Programme (FASP)Programme. The purpose of the service specification is to outline the service and quality indicators expected by NHS England (NHS E) for the NHS E responsible population for whom it is responsible and which meets the policies, recommendations and standards of the NHS Screening programmesProgrammes. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions which may apply, e.g. the Health and Social Care Act 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should needs to be read in conjunction withwith the following: • current FASP guidance xxxxx://xxx.xxx.xx/topic/population-screening- programmesSCT Screening Programme Standards xxxx://xxx.xxxxxxxxx.xxx.xx/standards xxxxx://xxx.xxx.xx/government/collections/nhs-population-screening-programme- standards Sickle Cell and Thalassaemia Handbook for Laboratories xxxxx://xxx.xxx.xx/government/publications/sickle-cell-and-thalassaemia-screening- handbook-for-laboratories NHS Newborn Blood Spot Screening Programme service specification. xxxxx://xxx.xxxxxxx.xxx.xx/commissioning/wp-content/uploads/sites/12/2016/04/serv- spec-19-chld-blood-spot-screening.pdf Specialised Haemoglobinopathy Services definition as set out in the Manual for prescribed specialised services The Specification for Specialised Services for Haemoglobinopathy Care (All Ages) (B08/fetal-anomaly • FASP Ultrasound Practitioners Handbook xxxxx://xxx.xxx.xx/government/publications/fetal-anomaly- S/a) NICE clinical guideline 62. Antenatal care xxxxx://xxx.xxxx.xxx.xx/guidance/cg62 NICE Clinical Guideline 110. Pregnancy and Social Complex Factors: A Model for Service Provision for Pregnant Women with Complex Social Factors. xxxxx://xxx.xxxx.xxx.xx/guidance/cg110 Guidance and updates on KPIs xxxxx://xxx.xxx.xx/government/collections/nhs- screening-ultrasoundprogrammes-practitionersnational-handbook • FASP Laboratory Handbook xxxxx://xxx.xxx.xx/government/publications/fetal- anomalydata-screening-laboratory-handbook-xxxxx-xxxxxxx-and-pataus- syndromes • any separate service specifications for the screening laboratory used by the Provider for antenatal screening services • UK NSC Guidancereporting NHS Screening Programmes guidance, Managing Safety Serious Incidents in the English NHS National Screening Programmes xxxxx://xxx.xxx.xx/government/publications/managing-safety-incidents-in- nhs-xxxxx://xxx.xxx.xx/government/publications/managing-safety-incidents-in-nhs- screening-programmes • Guidance & updates on Key Performance Indicators xxxxx://xxx.xxx.xx/government/collections/nhs-screening-programmes-national- data-reporting • Clinical Excellence (NICE) Clinical guideline 62 Antenatal care June 2010 xxxx://xxx.xxxx.xxx.xx/guidance/CG62 • National Institute for Health and Clinical Excellence (NICE) Clinical guideline CG 129 Antenatal care September 2011 • Royal College of Radiologists. xxxxx://xxx.xxx.xx.xx/publication/standards- provision-ultrasound-service • Service Specification Number 17 Fetal Anomaly Screening xxxxx://xxx.xxxxxxx.xxx.xx/commissioning/wp-content/uploads/sites/12/2016/02/serv- spec-17.pdf • ‘Maternity Pathway Payments: Who pays for what?-Aspects what: Aspects of the Maternity Pathway Payment maternity pathway payment for the Screening screening and Immunisations Programmes immunisation programmes June 2015 xxxxx://xxx.xxxxxxx.xxx.xx/expo/wp- content/uploads/sites/18/2015/06/who-pays-mpp-upd-06-2015.pdf2015

Purpose of the Specification. To ensure a consistent and equitable approach across England a common national service specification must be used to govern the provision and monitoring of Down’s, Xxxxxxx’ and Patau’s syndromes Screening (Trisomy 21, 18 &13) as part of the Fetal Anomaly Screening Programme (FASP). The purpose of the service specification is to outline the service and quality indicators expected by NHS England for the population for whom it is responsible and which meets the policies, recommendations and standards of the NHS Screening programmes. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions which may apply, e.g. the Health and Social Care Act 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • current FASP guidance xxxxx://xxx.xxx.xx/topic/population-screening- programmes/fetal-anomaly • FASP Ultrasound Practitioners Handbook xxxxx://xxx.xxx.xx/government/publications/fetal-anomaly- screening-ultrasound-practitioners-handbook • FASP Laboratory Handbook xxxxx://xxx.xxx.xx/government/publications/fetal- anomaly-screening-laboratory-handbook-xxxxx-xxxxxxx-and-pataus- syndromes • any separate service specifications for the screening laboratory used by the Provider for antenatal screening services • UK NSC Guidance, Managing Safety Incidents in the English NHS National Screening Programmes xxxxx://xxx.xxx.xx/government/publications/managing-safety-incidents-in- nhs-screening-programmes • Guidance & updates on Key Performance Indicators xxxxx://xxx.xxx.xx/government/collections/nhs-screening-programmes-national- data-reporting • Clinical Excellence (NICE) Clinical guideline 62 Antenatal care June 2010 xxxx://xxx.xxxx.xxx.xx/guidance/CG62 • National Institute for Health and Clinical Excellence (NICE) Clinical guideline CG 129 Antenatal care September 2011 • Royal College of Radiologists. xxxxx://xxx.xxx.xx.xx/publication/standards- provision-ultrasound-service • Service Specification Number 17 Fetal Anomaly Screening xxxxx://xxx.xxxxxxx.xxx.xx/commissioning/wp-content/uploads/sites/12/2016/02/serv- spec-17.pdf • ‘Maternity Pathway Payments: Who pays for what?-Aspects of the Maternity Pathway Payment for the Screening and Immunisations Programmes June 2015 xxxxx://xxx.xxxxxxx.xxx.xx/expo/wp- content/uploads/sites/18/2015/06/who-pays-mpp-upd-06-2015.pdfxxxxx://xxx.xxxxxxx.xxx.xx/commissioning/wp-content/uploads/sites/12/2016/04/serv- spec-17-apr16.pdf

Purpose of the Specification. To ensure a consistent and equitable approach across England a common national service specification must be used to govern the provision and monitoring of Down’s, Xxxxxxx’ and Patau’s syndromes Screening (Trisomy 21, 18 &13) fetal anomaly ultrasound screening services as part of the Fetal Anomaly Screening Programme (FASP). The purpose of the service specification is to outline the service and quality indicators expected by NHS England for the population for whom it is responsible and which meets the policies, recommendations and standards of the NHS Screening programmesFetal anomaly screening programme. The service This specification is not designed designated to replicate, duplicate or supersede any relevant legislative provisions which may apply, e.g. of the Health and Social Care Act 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • current FASP guidance xxxxx://xxx.xxx.xx/topic/population-screening- programmes/fetal-anomaly • FASP Screening programme handbook xxxxx://xxx.xxx.xx/government/publications/fetal-anomaly-screening- programme-handbook . • FASP Ultrasound Practitioners Handbook xxxxx://xxx.xxx.xx/government/publications/fetal-anomaly- screening-ultrasound-xxxxx://xxx.xxx.xx/government/publications/fetal-anomaly-screening-ultrasound- practitioners-handbook • FASP Laboratory Handbook xxxxx://xxx.xxx.xx/government/publications/fetal- anomaly-screening-laboratory-handbook-xxxxx-xxxxxxx-and-pataus- syndromes • any separate service specifications for the screening laboratory used by the Provider for antenatal screening services • UK NSC Guidance, Managing Safety Incidents in the English NHS National Screening Programmes xxxxx://xxx.xxx.xx/government/publications/managing-safety-incidents-in- nhs-screening-programmes • Guidance & updates on Key Performance Indicators can be found at xxxxx://xxx.xxx.xx/government/collections/nhs-screening-programmes-national- data-reporting • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 62 Antenatal care June 2010 xxxx://xxx.xxxx.xxx.xx/guidance/CG62 • National Institute for Health and Clinical Excellence (NICE) Clinical guideline CG 129 Antenatal care September 2011 xxxx://xxx.xxxx.xxx.xx/guidance/CG129 • Royal College of Radiologists. xxxxx://xxx.xxx.xx.xx/publication/standards- provision-ultrasound-service Providing an Ultrasound Service xxxxx://xxx.xxx.xx.xx/publication/standards-provision-ultrasound-service • Service Specification Number 17 specification No16 NHS Fetal Anomaly Screening xxxxx://xxx.xxxxxxx.xxx.xx/commissioning/wp-content/uploads/sites/12/2016/02/serv- spec-17.pdf Programme – Screening for Down’s, Xxxxxxx’ and Patau’s syndromes ( trisomy 21,18 & 13) xxxxx://xxx.xxxxxxx.xxx.xx/commissioning/wp- content/uploads/sites/12/2016/02/serv-spec-16.pdf • ‘Maternity Pathway Payments: Who pays for what?-Aspects of the Maternity Pathway Payment for the Screening and Immunisations Programmes June 2015 xxxxx://xxx.xxxxxxx.xxx.xx/expo/wp- content/uploads/sites/18/2015/06/who-pays-mpp-upd-06-2015.pdf